ADVAIR DISKUS 50 ug/1 (Fluticasone Propionate and Salmeterol POWDER) 50 ug/1

ADVAIR DISKUS 50 ug/1 combines fluticasone propionate and salmeterol for respiratory conditions. This powder inhaler offers a dual-action formula for managing symptoms. Ideal for those seeking effective respiratory support.

Strength

50 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0696-04) / 14 POWDER in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAIR DISKUS 50 ug/1 is commonly used for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). The combination of fluticasone propionate and salmeterol helps reduce inflammation and relax airway muscles. This inhaler is often prescribed to improve breathing and prevent symptoms such as wheezing and shortness of breath.

Side Effects

Users of ADVAIR DISKUS 50 ug/1 may experience improved breathing and reduced respiratory symptoms. Some individuals might notice side effects like throat irritation or hoarseness. It's important to use the inhaler as directed to minimize potential discomfort.

Precautions & Warnings

ADVAIR DISKUS 50 ug/1 should be used under medical supervision. It's important to follow the prescribed dosage and administration instructions. Regular monitoring is recommended, especially for those with underlying health conditions.

Avoid Interactions

ADVAIR DISKUS 50 ug/1 may interact with other medications, including beta-blockers and certain antifungal drugs. It's advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ADVAIR DISKUS 50 ug/1 is used to manage respiratory conditions like asthma and COPD. It helps reduce inflammation and relax airway muscles.

ADVAIR DISKUS 50 ug/1 is a powder inhaler. Follow your healthcare provider's instructions for proper usage and dosage.

Common side effects may include throat irritation and hoarseness. Always consult your healthcare provider if you experience any adverse effects.

ADVAIR DISKUS 50 ug/1 may be available for purchase online from authorized retailers. Ensure you are buying from a reputable source.

Long-term use of ADVAIR DISKUS 50 ug/1 should be monitored by a healthcare provider. Regular check-ups are recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.